TrivarX

TrivarX EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of TrivarX (TRI.AX) as of Nov 3, 2026 is -17.62. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -146.33 — a change of -87.96% (higher).

EV/OCF

-17.62

YoY

-87.96%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of TrivarX is 2026 -17.62 . EV/OCF (Enterprise Value to Operating Cash Flow) of TrivarX was 2025 -146.33 . It decreases by -87.96% higher compared to the previous year.

The TrivarX EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2019
-4.42 AUD
Jan 1, 2020
-7.83 AUD
Jan 1, 2021
-15.61 AUD
Jan 1, 2022
-2.27 AUD
Jan 1, 2023
-30.83 AUD
Jan 1, 2024
-18.98 AUD
Jan 1, 2025
-146.33 AUD
Jan 1, 2026
-17.62 AUD
The TrivarX EV/OCF history
YEAREV/OCFYoY
-17.62-87.96%
-146.33+670.78%
-18.98-38.41%
-30.83+1,257.44%
-2.27-85.46%
-15.61+99.35%
-7.83+77.25%
-4.42+137.35%
-1.86-57.86%
-4.42-62.12%
-11.66-44.08%
-20.85-58.40%
-50.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TrivarX Stock analysis

What does TrivarX do? TrivarX Ltd generates revenue through its corporate health product, which provides mental well-being solutions for businesses. The company develops and commercializes mental health technology using objective biomarkers for screening, diagnosing, monitoring, and managing depression. Its consumer mobile application LUCA offers biometric assessments measuring sleep stress, activity stress, and cardiac stress, enabling users to monitor stress levels via personal wearable devices. The company focuses on early detection and screening of mental health conditions through clinical research and product development. The primary buyers of TrivarX's corporate health product are businesses seeking mental well-being solutions for their employees. The consumer application LUCA targets individuals interested in monitoring their stress levels using wearable technology. TrivarX's technology is designed to assist in the early detection and screening of mental health conditions, with a focus on depression management through objective biomarker analysis. The company's clinical research and product development activities support both business and consumer segments in the mental health technology market. TrivarX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TrivarX stock

EV/OCF (Enterprise Value to Operating Cash Flow) of TrivarX is -17.62 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of TrivarX changed from -146.33 to -17.62, representing a -87.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) TrivarX since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s TrivarX with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — TrivarX

All Key Metrics — TrivarX